GO:0007169 cell surface receptor protein tyrosine kinase signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0007169 describes the molecular signaling cascade triggered when an extracellular ligand binds to a cell surface receptor that possesses intrinsic tyrosine kinase activity, ultimately regulating downstream cellular processes such as transcription.
• Receptor tyrosine kinases (RTKs) are the central receptors in this pathway, and their activation involves ligand-induced dimerization, autophosphorylation, and recruitment of downstream signaling proteins.
• This pathway is highly conserved and essential for fundamental processes including cell growth, differentiation, metabolism, and survival, as well as specialized functions like fertilization and immune responses.
• Dysregulation of RTK signaling is a major driver of human cancers, with oncogenic activation of receptors such as RON leading to uncontrolled proliferation and survival.
• Non-receptor tyrosine kinases, such as Src and JAK family members, often act as downstream effectors or modulators of RTK signaling, expanding the pathway's regulatory complexity.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are powerful tools for dissecting the causal roles of individual components within this pathway and for validating therapeutic targets.
Description
The cell surface receptor protein tyrosine kinase signaling pathway (GO:0007169) is a fundamental biological process that enables cells to sense and respond to their external environment. It is initiated when an extracellular ligand binds to a receptor on the target cell surface that possesses tyrosine kinase activity, leading to the activation of a cascade of intracellular molecular signals that ultimately regulate diverse cellular processes, including transcription. This pathway is central to metazoan development and tissue homeostasis, controlling decisions such as whether a cell should grow, divide, differentiate, or survive. Given its broad importance, mutations or dysregulation in components of this pathway are implicated in numerous human diseases, most notably cancer, making it a prime focus for both basic research and therapeutic intervention. Understanding the precise molecular events and the genes involved is therefore critical for researchers in cell biology, oncology, and drug discovery.
cell surface receptor protein tyrosine kinase signaling pathway At A Glance
| GO ID | GO:0007169 |
|---|---|
| GO term | cell surface receptor protein tyrosine kinase signaling pathway |
| Ontology | biological_process |
| Synonym | transmembrane receptor protein serine/threonine kinase signaling pathway; transmembrane receptor protein tyrosine kinase signalling pathway |
| Major function | Transmits extracellular signals into the cell via receptor tyrosine kinases to regulate gene expression and cellular responses. |
| Key receptors | Receptor tyrosine kinases (RTKs) such as EGFR, FGFR, PDGFR, and RON. |
| Key downstream effectors | Non-receptor tyrosine kinases (e.g., Src, JAK), adaptor proteins, and transcription factors. |
| Associated diseases | Cancer, developmental disorders, and immune dysregulation. |
| Research methods | CRISPR knockout/knock-in, phosphoproteomics, RNA-seq, and cell-based signaling assays. |
What Is GO:0007169?
According to the Gene Ontology, GO:0007169 is defined as the series of molecular signals initiated by an extracellular ligand binding to a receptor on the surface of the target cell where the receptor possesses tyrosine kinase activity, and ending with the regulation of a downstream cellular process, e.g. transcription. In simpler terms, it is the entire communication chain that starts when a signaling molecule docks onto a specific receptor on the cell surface, and this receptor then uses its enzymatic activity to add phosphate groups to tyrosine residues on itself and other proteins, propagating a signal inside the cell that changes what the cell does.
Why Is cell surface receptor protein tyrosine kinase signaling pathway Important in Cell Biology?
The cell surface receptor protein tyrosine kinase signaling pathway is critically important because it serves as a primary mechanism by which cells interpret and respond to a vast array of external cues, including growth factors, hormones, and cytokines. This pathway governs essential physiological processes ranging from embryonic development and tissue repair to immune surveillance and metabolic regulation. Consequently, when components of this pathway are mutated or aberrantly activated, they can drive pathological conditions, most prominently cancer, where oncogenic RTK signaling promotes uncontrolled cell proliferation and survival. Therefore, studying this pathway is not only fundamental to understanding basic cell biology but also essential for identifying therapeutic targets and developing precision medicines.
• Controls fundamental cellular decisions including proliferation, differentiation, survival, and migration.
• Essential for embryonic development and organogenesis across metazoans.
• Plays a specialized role in fertilization, where tyrosine kinase signaling is required for egg activation.
• Regulates immune cell functions, including neutrophil activation and chemotaxis.
• Dysregulation is a hallmark of many cancers, with RTKs frequently mutated or overexpressed.
• Serves as a major target class for approved anticancer drugs (e.g., tyrosine kinase inhibitors).
• Integrates with other signaling pathways, such as G protein-coupled receptor signaling, through tyrosine kinase-mediated cross-talk.
• Involved in Wnt-frizzled signaling to G-protein-coupled effectors, highlighting its broader regulatory reach.
• Provides a paradigm for understanding signal transduction mechanisms, including receptor dimerization and autophosphorylation.
• Offers numerous targets for CRISPR-based functional genomics and drug discovery.
What Happens During cell surface receptor protein tyrosine kinase signaling pathway?
Ligand Binding and Receptor Activation
In simple terms: A signaling molecule from outside the cell attaches to a receptor on the cell surface, causing the receptor to switch on.
The pathway begins when an extracellular ligand, such as a growth factor, binds to the extracellular domain of a receptor tyrosine kinase (RTK). This binding typically induces receptor dimerization or oligomerization, bringing the intracellular kinase domains into close proximity. This allows the receptors to phosphorylate each other on specific tyrosine residues, a process known as autophosphorylation, which is the critical activation step.
Recruitment of Downstream Signaling Proteins
In simple terms: The activated receptor creates docking sites that attract other proteins inside the cell, passing the signal along.
The phosphotyrosine residues on the activated receptor serve as docking sites for various downstream signaling proteins that contain Src homology 2 (SH2) or phosphotyrosine-binding (PTB) domains. These proteins include adaptor molecules (e.g., Grb2), enzymes (e.g., PI3K, PLC-gamma), and non-receptor tyrosine kinases (e.g., Src family kinases). The recruitment and subsequent activation of these proteins propagate the signal.
Signal Transduction Cascades
In simple terms: A chain reaction of protein modifications inside the cell amplifies the signal and sends it to different destinations.
Once recruited, downstream effectors initiate multiple signaling cascades. A major route is the RAS-MAPK pathway, where the adaptor Grb2 recruits the guanine nucleotide exchange factor SOS, activating RAS, which then activates a kinase cascade (RAF, MEK, ERK) that translocates to the nucleus to regulate transcription. Another key pathway is the PI3K-AKT pathway, which promotes cell survival and growth. Phospholipase C-gamma (PLC-gamma) is also activated, leading to calcium release and protein kinase C (PKC) activation.
Regulation of Downstream Cellular Processes
In simple terms: The signal finally reaches the cell's control center, changing which genes are turned on or off and altering cell behavior.
The ultimate outcome of the signaling cascade is the regulation of diverse cellular processes. This includes changes in gene expression through the activation of transcription factors (e.g., ERK phosphorylates and activates transcription factors like Elk-1), leading to altered programs of cell proliferation, differentiation, or survival. The pathway also regulates cytoskeletal rearrangements, metabolism, and cell motility. The specificity of the response is determined by the combination of receptors, ligands, and downstream effectors present in a given cell type.
Signal Attenuation and Termination
In simple terms: The cell has built-in brakes to shut off the signal once it has done its job, preventing overactivity.
To avoid excessive signaling, the pathway is tightly regulated by negative feedback mechanisms. These include receptor internalization and degradation, dephosphorylation by protein tyrosine phosphatases (PTPs), and the action of negative regulators such as Sprouty proteins and SOCS proteins. Ubiquitination and degradation of activated receptors also contribute to signal termination. Dysregulation of these attenuation mechanisms can lead to sustained signaling and oncogenesis.
Key Genes Involved in GO:0007169 cell surface receptor protein tyrosine kinase signaling pathway
The following table lists key genes and proteins that are core components or regulators of the cell surface receptor protein tyrosine kinase signaling pathway, along with their major roles and relevance to research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EGFR | Receptor tyrosine kinase that binds EGF; activates MAPK and PI3K pathways | Mutated/overexpressed in many cancers; major drug target |
| FGFR1 | Receptor tyrosine kinase for FGF; regulates proliferation and differentiation | Implicated in developmental disorders and cancers |
| PDGFRA | Receptor tyrosine kinase for PDGF; controls cell growth and survival | Oncogenic mutations in gastrointestinal stromal tumors |
| INSR | Receptor tyrosine kinase for insulin; regulates glucose metabolism | Key target for diabetes research |
| SRC | Non-receptor tyrosine kinase; downstream effector of RTKs | Proto-oncogene; regulates proliferation and adhesion |
| JAK2 | Non-receptor tyrosine kinase; mediates cytokine receptor signaling | Mutations in myeloproliferative neoplasms |
| GRB2 | Adaptor protein; links RTKs to RAS-MAPK pathway | Essential for RTK-mediated proliferation |
| PIK3CA | Catalytic subunit of PI3K; generates PIP3 for AKT activation | Frequently mutated in cancers |
| AKT1 | Serine/threonine kinase; promotes survival and growth | Oncogene; target for cancer therapy |
| MAPK1 (ERK2) | Serine/threonine kinase; transmits signals to nucleus | Central node in RTK signaling; drug target |
| PTPN11 (SHP2) | Protein tyrosine phosphatase; positive regulator of RTK signaling | Mutations in Noonan syndrome and leukemia |
| CBL | E3 ubiquitin ligase; mediates RTK degradation | Negative regulator; mutations in cancers |
| RON (MST1R) | Receptor tyrosine kinase; activates oncogenic pathways | Overexpressed in cancers; promotes metastasis |
| FRS2 | Adaptor protein; links FGFR to MAPK | Critical for FGF signaling |
| PLC-gamma1 | Phospholipase; hydrolyzes PIP2 to IP3 and DAG | Mediates RTK signaling to PKC and calcium |
| STAT3 | Transcription factor; activated by JAK kinases downstream of RTKs | Oncogenic; regulates proliferation and survival |
| SOCS1 | Negative regulator of cytokine/RTK signaling | Suppresses excessive signaling; tumor suppressor |
| SPRY2 | Negative regulator of RTK-RAS-MAPK pathway | Modulates signaling duration and intensity |
How Is cell surface receptor protein tyrosine kinase signaling pathway Regulated?
The cell surface receptor protein tyrosine kinase signaling pathway is subject to multiple layers of regulation to ensure appropriate signal strength and duration. Key negative regulators include protein tyrosine phosphatases (PTPs) such as SHP-1 and PTEN (which dephosphorylates PIP3), which counteract kinase activity. Ubiquitin ligases like CBL promote receptor endocytosis and degradation, thereby terminating signaling. Additionally, feedback inhibitors such as Sprouty and SOCS proteins are transcriptionally induced by the pathway itself and act to dampen the signal. Dysregulation of these control mechanisms, often through mutation or epigenetic silencing, can lead to sustained oncogenic signaling.
cell surface receptor protein tyrosine kinase signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EGFR | Non-small cell lung cancer, glioblastoma | Knockout and point mutation (e.g., L858R) in cancer cell lines |
| RON (MST1R) | Breast and colon cancer metastasis | Overexpression and knockout in cancer cell lines |
| PTPN11 | Noonan syndrome, juvenile myelomonocytic leukemia | Knock-in of disease-associated mutations in iPSCs or mice |
| JAK2 | Myeloproliferative neoplasms | Knock-in of V617F mutation in hematopoietic stem cells |
| FGFR3 | Achondroplasia, bladder cancer | Point mutation knock-in in chondrocytes or cancer cells |
Cancer
Aberrant activation of receptor tyrosine kinase signaling is a hallmark of many human cancers. Oncogenic mutations, gene amplifications, or autocrine loops can lead to constitutive activation of RTKs such as EGFR, FGFR, and RON, driving uncontrolled proliferation, survival, and metastasis. For example, RON receptor tyrosine kinase activates multiple oncogenic signaling pathways, including RAS-MAPK and PI3K-AKT, and its overexpression correlates with poor prognosis in various carcinomas. Targeting these pathways with tyrosine kinase inhibitors has proven to be a successful therapeutic strategy in several malignancies.
Developmental Disorders
Germline mutations in components of the RTK signaling pathway can cause developmental syndromes. For instance, mutations in PTPN11 (encoding SHP2), a positive regulator of RTK signaling, are responsible for Noonan syndrome, which is characterized by craniofacial dysmorphism, cardiac defects, and short stature. Similarly, mutations in FGFR genes cause skeletal dysplasias such as achondroplasia. These disorders highlight the critical role of precise RTK signaling in embryonic development.
Immune Dysregulation
Tyrosine kinase signaling pathways are essential for immune cell development and function. In neutrophils, for example, tyrosine kinase signaling downstream of cytokine and chemokine receptors regulates chemotaxis, phagocytosis, and production of reactive oxygen species. Dysregulation can lead to inflammatory diseases or immunodeficiency. JAK2 mutations are also associated with myeloproliferative neoplasms, underscoring the importance of this pathway in hematopoiesis.
From cell surface receptor protein tyrosine kinase signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of RTK X impair downstream signaling? | CRISPR knockout cell line (e.g., HEK293, HeLa) |
| Does a specific point mutation in RTK X alter kinase activity? | CRISPR point mutation knock-in (e.g., kinase-dead or constitutively active) |
| Does tagging RTK X with a fluorescent protein affect its localization? | CRISPR knock-in of GFP or HA tag |
| Does overexpression of RTK X drive oncogenic transformation? | CRISPR overexpression (e.g., via safe-harbor locus) or lentiviral transduction |
| Which genes are essential for RTK signaling in a specific cancer? | Genome-wide CRISPR library screening |
| How does a disease-associated mutation affect signaling dynamics? | Patient-derived iPSCs with isogenic CRISPR correction |
How to Study the cell surface receptor protein tyrosine kinase signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phosphoproteomics | Global tyrosine phosphorylation changes | Identify RTK substrates and signaling networks |
| RNA-seq | Transcriptional changes | Define gene expression programs downstream of RTKs |
| CRISPR knockout screening | Gene essentiality for pathway activity | Discover novel regulators of RTK signaling |
| Western blot | Protein phosphorylation and expression | Validate specific signaling events |
| Immunoprecipitation | Protein-protein interactions | Study receptor complex formation |
| FRET biosensors | Real-time kinase activity | Monitor signaling dynamics in live cells |
| Cell proliferation assays | Cell growth and survival | Assess functional outcomes of RTK signaling |
| Xenograft mouse models | Tumor growth in vivo | Evaluate oncogenic potential of RTK mutations |
Phosphoproteomics
Mass spectrometry-based phosphoproteomics allows global profiling of tyrosine phosphorylation events following RTK activation. This method can identify novel substrates and quantify changes in signaling networks in response to ligands or inhibitors. It is particularly useful for mapping the immediate downstream effects of specific RTK mutations.
RNA Sequencing (RNA-seq)
RNA-seq measures changes in gene expression induced by RTK signaling. By comparing transcriptomes of cells with activated or inhibited RTKs, researchers can identify transcriptional programs controlled by the pathway. This is valuable for understanding how signaling rewires gene expression in cancer and other diseases.
CRISPR-Based Functional Genomics
CRISPR knockout and activation screens enable systematic interrogation of genes required for RTK signaling. For example, a genome-wide knockout screen can identify genes whose loss sensitizes or confers resistance to RTK inhibitors. This approach is powerful for discovering new therapeutic targets and understanding pathway architecture.
Live-Cell Imaging
Fluorescently tagged RTKs and downstream effectors can be visualized in live cells to study receptor trafficking, dimerization, and signaling dynamics. Techniques such as FRET biosensors allow real-time monitoring of kinase activity and second messenger production, providing spatiotemporal insights into pathway regulation.
How CRISPR Can Be Used to Study GO:0007169 cell surface receptor protein tyrosine kinase signaling pathway
Knockout
CRISPR knockout is used to completely ablate a gene of interest to determine its necessity in the RTK signaling pathway. For example, knocking out EGFR in cancer cell lines can reveal whether the cells depend on EGFR for proliferation and survival. This approach is also used in genome-wide screens to identify genes required for pathway activity.
Point Mutation
CRISPR point mutation knock-in allows the introduction of specific disease-associated or functional mutations into the endogenous locus. This is critical for studying how mutations such as kinase-domain substitutions affect RTK activity, downstream signaling, and cellular phenotypes. It provides a more physiologically relevant context than overexpression.
Knock-in
CRISPR knock-in can be used to tag endogenous RTKs or signaling proteins with fluorescent or affinity tags, enabling visualization and biochemical purification. It can also be used to insert reporter genes under the control of pathway-responsive promoters, allowing real-time monitoring of signaling output.
Overexpression
CRISPR-mediated overexpression, often achieved by inserting a strong promoter or using CRISPR activation (CRISPRa), is used to study the effects of elevated RTK levels, as seen in cancers with gene amplification. This approach helps determine whether increased dosage of a receptor is sufficient to drive oncogenic transformation.
How EDITGENE Supports cell surface receptor protein tyrosine kinase signaling pathway Research
Researchers studying cell surface receptor protein tyrosine kinase signaling pathway-related genes often need to determine whether a candidate gene is causally involved in pathway activity, disease progression, or drug response. Generating precise, isogenic cell models is essential to move from correlation to causation. EDITGENE provides a comprehensive suite of CRISPR-based services to support every stage of this research, from initial target validation to functional genomics screens.
Contact EDITGENE today to design your custom CRISPR model for cell surface receptor protein tyrosine kinase signaling pathway research.
Frequently Asked Questions About cell surface receptor protein tyrosine kinase signaling pathway
What is the cell surface receptor protein tyrosine kinase signaling pathway?
It is the process defined by GO:0007169, where an extracellular ligand binds to a cell surface receptor with tyrosine kinase activity, triggering a series of intracellular signals that regulate cellular processes such as transcription.
What genes are involved in cell surface receptor protein tyrosine kinase signaling pathway?
Key genes include receptor tyrosine kinases like EGFR, FGFR1, PDGFRA, and INSR, as well as downstream effectors such as SRC, JAK2, GRB2, PIK3CA, AKT1, and MAPK1.
What is the function of receptor tyrosine kinases?
Receptor tyrosine kinases (RTKs) are cell surface receptors that, upon ligand binding, autophosphorylate and recruit downstream signaling proteins to control cell growth, differentiation, and survival.
How is the cell surface receptor protein tyrosine kinase signaling pathway regulated?
It is regulated by negative feedback mechanisms including protein tyrosine phosphatases, ubiquitin ligases like CBL, and inhibitors such as Sprouty and SOCS proteins.
What diseases are associated with defects in this pathway?
Dysregulation of this pathway is linked to many cancers (e.g., EGFR-mutant lung cancer, RON-overexpressing tumors), developmental disorders (e.g., Noonan syndrome), and immune disorders.
What are the main steps in RTK signaling?
The main steps are ligand binding and receptor dimerization, autophosphorylation, recruitment of downstream proteins, activation of signaling cascades (e.g., MAPK, PI3K-AKT), and regulation of cellular responses.
How can CRISPR be used to study RTK signaling?
CRISPR can create knockout, point mutation knock-in, tagged knock-in, and overexpression models to dissect gene function and validate drug targets in the pathway.
What is the role of non-receptor tyrosine kinases in this pathway?
Non-receptor tyrosine kinases such as SRC and JAK family members act as downstream effectors or modulators, amplifying and diversifying the signal initiated by RTKs.
Which methods are used to study cell surface receptor protein tyrosine kinase signaling?
Common methods include phosphoproteomics, RNA-seq, Western blotting, immunoprecipitation, live-cell imaging, and CRISPR-based functional screens.
Why is the cell surface receptor protein tyrosine kinase signaling pathway important for cancer research?
Because mutations or overexpression of RTKs and their downstream effectors drive cancer cell proliferation and survival, making them key therapeutic targets.
Conclusion
The cell surface receptor protein tyrosine kinase signaling pathway (GO:0007169) is a cornerstone of cellular communication, translating extracellular cues into profound changes in cell behavior. Its dysregulation underlies a wide range of human diseases, particularly cancer, making it a central focus of biomedical research. Advances in CRISPR-based models and functional genomics are providing unprecedented opportunities to dissect the pathway's complexity and identify new therapeutic vulnerabilities. Continued research into this pathway promises to yield further insights into basic biology and to drive the development of next-generation targeted therapies.
References
- 1. Neet K et al.. 1996. Vertebrate non-receptor protein-tyrosine kinase families.. Genes Cells 1(2):147-69 PMID: 9140060
- 3. Cadena DL et al.. 1992. Receptor tyrosine kinases.. FASEB J 6(6):2332-7 PMID: 1312047
- 4. Kinsey WH. 1997. Tyrosine kinase signaling at fertilization.. Biochem Biophys Res Commun 240(3):519-22 PMID: 9398596
- 5. Futosi K et al.. 2016. Tyrosine kinase signaling pathways in neutrophils.. Immunol Rev 273(1):121-39 PMID: 27558332
- 6. Dikic I et al.. 1999. Protein tyrosine kinase-mediated pathways in G protein-coupled receptor signaling.. Cell Biochem Biophys 30(3):369-87 PMID: 10403057
- 7. Wang HY et al.. 2004. Wnt-frizzled signaling to G-protein-coupled effectors.. Cell Mol Life Sci 61(1):69-75 PMID: 14704854
- 8. Danilkovitch-Miagkova A. 2003. Oncogenic signaling pathways activated by RON receptor tyrosine kinase.. Curr Cancer Drug Targets 3(1):31-40 PMID: 12570659
